Earnings
West Pharmaceutical (WST) Sets 2024 EPS Guidance at $7.50-$7.75
WST reported a robust fourth-quarter with net sales of $732.0 million, marking a 3.3% increase.
BTC$62,291.00+3.20%
ETH$1,626.48+5.83%
USDT$0.9995+0.00%
USDC$0.9996+0.00%
XRP$1.14+5.57%
SOL$64.60+5.18%
TRX$0.3286+3.15%
FIGR_HELOC$1.03+0.46%
HYPE$58.79+0.64%
DOGE$0.0843+5.16%
USDS$0.9997+0.01%
LEO$9.55-0.31%
RAIN$0.0134+4.90%
XLM$0.2048+5.05%
ZEC$398.76+9.00%
BTC$62,291.00+3.20%
ETH$1,626.48+5.83%
USDT$0.9995+0.00%
USDC$0.9996+0.00%
XRP$1.14+5.57%
SOL$64.60+5.18%
TRX$0.3286+3.15%
FIGR_HELOC$1.03+0.46%
HYPE$58.79+0.64%
DOGE$0.0843+5.16%
USDS$0.9997+0.01%
LEO$9.55-0.31%
RAIN$0.0134+4.90%
XLM$0.2048+5.05%
ZEC$398.76+9.00%
Recent earnings reports from Iron Mountain, US Foods, and West Pharmaceutical Services reveal strong performances and promising guidance for 2026.
WST reported a robust fourth-quarter with net sales of $732.0 million, marking a 3.3% increase.